Publications in collaboration with researchers from Universitat d'Alacant (1)

2017

  1. Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

    Journal of Thoracic Oncology, Vol. 12, Núm. 4, pp. 752-762